Abstract
The clinical translation of the multiple pharmacological effects of resveratrol (RSV) found in preclinical studies has been impaired by its poor bioavailability, due to poor solubility and rapid metabolism and elimination. The inclusion of this molecule in medicines or functional food products will be ineffective unless suitable systems are developed. Zein protein may constitute an inexpensive, safe, and effective choice to produce nanoparticles (NPs) to incorporate hydrophobic molecules and overcome the bioavailability issues of RSV. In this work, we loaded RSV into zein NPs by using a nanoprecipitation method. Unloaded and RSV-loaded NPs presented average diameter values in the range of 120–180 nm, narrow size distribution (polydispersity index < 0.150), and zeta potential of around + 20 mV. The association efficiency of the drug was equal to or greater than 77% for different initial drug loads. Scanning electron microscopy imaging revealed that zein NPs were round-shaped and presented a smooth surface. Aqueous suspensions of zein NPs were stable for at least 1 month when stored at 4 °C. The freeze-drying of zein NPs using sucrose as cryoprotectant allowed an easy re-suspension of NPs in water without significantly changing the initial colloidal properties. RSV-loaded NPs presented low cytotoxicity to the human colorectal Caco-2 and HT29-MTX cell lines. Finally, permeability studies of RSV across Caco-2 and Caco-2/HT29-MTX evidenced some ability of zein NPs to protect RSV from metabolism events. However, further investigation is needed in order to confirm the possible role of zein NPs in the metabolic stability of RSV. Overall, zein NPs may present the potential to circumvent bioavailability issues of RSV.
Similar content being viewed by others
References
Yu W, Fu YC, Wang W. Cellular and molecular effects of resveratrol in health and disease. J CellBiochem. 2012;113(3):752–9. https://doi.org/10.1002/jcb.23431.
Poulsen MM, Jørgensen JOL, Jessen N, Richelsen B, Pedersen SB. Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann N Y Acad Sci. 2013;1290(1):74–82. https://doi.org/10.1111/nyas.12141.
Neves AR, Lucio M, Lima JLC, Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem. 2012;19(11):1663–81. https://doi.org/10.2174/092986712799945085.
Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release. 2012;158(2):182–93. https://doi.org/10.1016/j.jconrel.2011.09.083.
Santos AC, Pereira I, Pereira-Silva M, Ferreira L, Caldas M, Collado-González M, et al. Nanotechnology-based formulations for resveratrol delivery: effects on resveratrol in vivo bioavailability and bioactivity. Colloids Surf B Biointerfaces. 2019;180:127–40. https://doi.org/10.1016/j.colsurfb.2019.04.030.
Fonte P, Araújo F, Silva C, Pereira C, Reis S, Santos HA, et al. Polymer-based nanoparticles for oral insulin delivery: revisited approaches. Biotechnol Adv. 2015;33(6, Part 3):1342–54. https://doi.org/10.1016/j.biotechadv.2015.02.010.
Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliv Rev. 2019;144:57–77. https://doi.org/10.1016/j.addr.2019.07.010.
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1):1–20. https://doi.org/10.1016/S0168-3659(00)00339-4.
Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 2007;59(6):478–90. https://doi.org/10.1016/j.addr.2007.04.007.
Garícia-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B: Biointerfaces. 2003;27(2):159–68. https://doi.org/10.1016/S0927-7765(02)00053-X.
Elzoghby AO, Samy WM, Elgindy NA. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release. 2012;161(1):38–49. https://doi.org/10.1016/j.jconrel.2012.04.036.
Yin L, Yuvienco C, Montclare JK. Protein based therapeutic delivery agents: contemporary developments and challenges. Biomaterials. 2017;134:91–116. https://doi.org/10.1016/j.biomaterials.2017.04.036.
Rowe RC, Sheskey PP, Cook WG, Fenton ME. Handbook of pharmaceutical excipients, vol. 2. 7th ed. London: Pharmaceutical Press; 2013.
Paliwal R, Palakurthi S. Zein in controlled drug delivery and tissue engineering. J Control Release. 2014;189:108–22. https://doi.org/10.1016/j.jconrel.2014.06.036.
Anderson TJ, Lamsal BP. Zein extraction from corn, corn products, and coproducts and modifications for various applications: a review. Cereal Chem. 2011;88(2):159–73.
Vasconcelos T, Araújo F, Lopes C, Loureiro A, das Neves J. Marques S et al Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile. Eur J Pharm Sci. 2019;137:105011. https://doi.org/10.1016/j.ejps.2019.105011.
Esen A. Separation of alcohol-soluble proteins (zeins) from maize into three fractions by differential solubility. Plant Physiol. 1986;80(3):623–7. https://doi.org/10.1104/pp.80.3.623.
Podaralla S, Perumal O. Influence of formulation factors on the preparation of zein nanoparticles. AAPS PharmSciTech. 2012;13(3):919–27. https://doi.org/10.1208/s12249-012-9816-1.
López-Nicolás JM, Garcia-Carmona F. Aggregation state and pKa values of (E)-resveratrol as determined by fluorescence spectroscopy and UV-visible absorption. J Agric Food Chem. 2008;56:7600–5.
Fonte P, Soares S, Costa A, Andrade JC, Seabra V, Reis S, et al. Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying. Biomatter. 2012;2(4):329–39. https://doi.org/10.4161/biom.23246.
Acharya DP, Sanguansri L, Augustin MA. Binding of resveratrol with sodium caseinate in aqueous solutions. Food Chem. 2013;141(2):1050–4. https://doi.org/10.1016/j.foodchem.2013.03.037.
Hemar Y, Gerbeaud M, Oliver CM, Augustin MA. Investigation into the interaction between resveratrol and whey proteins using fluorescence spectroscopy. J Food Sci Technol. 2011;46(10):2137–44. https://doi.org/10.1111/j.1365-2621.2011.02728.x.
Joye IJ, Davidov-Pardo G, Ludescher RD, McClements DJ. Fluorescence quenching study of resveratrol binding to zein and gliadin: towards a more rational approach to resveratrol encapsulation using water-insoluble proteins. Food Chem. 2015;185:261–7. https://doi.org/10.1016/j.foodchem.2015.03.128.
ISO 10993-5:2009(2009) Biological evaluation of medical devices-part 5: tests for in vitro cytotoxicity.
Dong J, Sun Q, Wang J-Y. Basic study of corn protein, zein, as a biomaterial in tissue engineering, surface morphology and biocompatibility. Biomaterials. 2004;25(19):4691–7. https://doi.org/10.1016/j.biomaterials.2003.10.084.
Liu B, Zhou Z, Zhou W, Liu J, Zhang Q, Xia J, et al. Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/Sphase cell cycle arrest and apoptosis through caspase/cyclinCDK pathways. Mol Med Rep. 2014;10(4):1697–702. https://doi.org/10.3892/mmr.2014.2406.
Yongmei L, Young Geun S, Chongwoo Y, Jerome WK, Wendy HH, John MP, et al. Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb Chem High Throughput Screen. 2003;6(8):757–67. https://doi.org/10.2174/138620703771826865.
Kaldas MI, Walle UK, Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol. 2003;55(3):307–12. https://doi.org/10.1211/002235702612.
Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, Jäger W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm Res. 2006;23(9):2107–15. https://doi.org/10.1007/s11095-006-9060-z.
Araújo F, Sarmento B. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies. Int J Pharm. 2013;458(1):128–34. https://doi.org/10.1016/j.ijpharm.2013.10.003.
Lechanteur A, das Neves J, Sarmento B. The role of mucus in cell-based models used to screen mucosal drug delivery. Adv Drug Deliv Rev. 2018;124:50–63. https://doi.org/10.1016/j.addr.2017.07.019.
Nunes R, Araújo F, Barreiros L, Bártolo I, Segundo MA, Taveira N, et al. Noncovalent PEG coating of nanoparticle drug carriers improves the local pharmacokinetics of rectal anti-HIV microbicides. ACS Appl Mater Interfaces. 2018;10(41):34942–53. https://doi.org/10.1021/acsami.8b12214.
Dong F, Padua GW, Wang Y. Controlled formation of hydrophobic surfaces by self-assembly of an amphiphilic natural protein from aqueous solutions. Soft Matter. 2013;9(25):5933–41. https://doi.org/10.1039/C3SM50667C.
Gagliardi A, Paolino D, Iannone M, Palma E, Fresta M, Cosco D. Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system. Int J Nanomedicine. 2018;13:601–14. https://doi.org/10.2147/ijn.s156930.
Lai S, Wang Y-Y, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158–71. https://doi.org/10.1016/j.addr.2008.11.002.
Macierzanka A, Rigby NM, Corfield AP, Wellner N, Böttger F, Mills ENC, et al. Adsorption of bile salts to particles allows penetration of intestinal mucus. Soft Matter. 2011;7(18):8077–84. https://doi.org/10.1039/C1SM05888F.
Inchaurraga L, Martínez-López AL, Abdulkarim M, Gumbleton M, Quincoces G, Peñuelas I, et al. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate. Int J Pharm. 2019;1:100006. https://doi.org/10.1016/j.ijpx.2019.100006.
Fernández-Carneado J, Kogan MJ, Castel S, Giralt E. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of γ-zein. Angew Chem Int Ed Engl. 2004;43(14):1811–4. https://doi.org/10.1002/anie.200352540.
Luo Y, Teng Z, Wang Q. Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem. 2012;60(3):836–43. https://doi.org/10.1021/jf204194z.
Lai LF, Guo HX. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm. 2011;404(1):317–23. https://doi.org/10.1016/j.ijpharm.2010.11.025.
Poquet L, Clifford MN, Williamson G. Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos. 2008;36(1):190–7. https://doi.org/10.1124/dmd.107.017558.
Jailani F, Williamson G. Effect of edible oils on quercetin, kaempferol and galangin transport and conjugation in the intestinal Caco-2/HT29-MTX co-culture model. Food Funct. 2014;5(4):653–62. https://doi.org/10.1039/C3FO60691K.
Funding
This work was financed by the project NORTE-01-0145-FEDER-000012 by Norte Portugal Regional Operational Programme (NORTE 2020) and COMPETE 2020 - Operacional Programme for Competitiveness and Internationalisation (POCI), under the PORTUGAL 2020 Partnership Agreement, through the FEDER - Fundo Europeu de Desenvolvimento Regional, and by Portuguese funds through FCT - Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior in the framework of the project “Institute for Research and Innovation in Health Sciences” UID/BIM/04293/2019 and NETDIAMOND (POCI-01-0145-FEDER-016385). The authors acknowledge the support of the i3S Scientific Platforms Biointerfaces and Nanotechnology.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 211 kb)
Rights and permissions
About this article
Cite this article
Nunes, R., Baião, A., Monteiro, D. et al. Zein nanoparticles as low-cost, safe, and effective carriers to improve the oral bioavailability of resveratrol. Drug Deliv. and Transl. Res. 10, 826–837 (2020). https://doi.org/10.1007/s13346-020-00738-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-020-00738-z